• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

越南乳腺癌女性中BRCA1、RASSF1A和GSTP1的甲基化谱

Methylation Profiles of BRCA1, RASSF1A and GSTP1 in Vietnamese Women with Breast Cancer.

作者信息

Vu Trang Lan, Nguyen Trang Thu, Doan Van Thi Hong, Vo Lan Thi Thuong

机构信息

Sorbonne University, UPMC Univ. Paris 06, École Normale Supérieure, PSL Research University, CNRS, INSERM, APHP, Laboratoire des Biomolécules (LBM), Paris, France. Email:

出版信息

Asian Pac J Cancer Prev. 2018 Jul 27;19(7):1887-1893. doi: 10.22034/APJCP.2018.19.7.1887.

DOI:10.22034/APJCP.2018.19.7.1887
PMID:30049201
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6165660/
Abstract

Objective: This study investigated the DNA promoter methylation profiles of BRCA1, RASSF1A and GSTP1 genes, both individually and in an integrative manner in order to clarify their correlation with clinicopathological parameters of breast cancer from Vietnamese patients, and establish new potential integrative methylation biomarkers for breast cancer detection. Material and methods: The methylation frequencies of BRCA1, RASSF1A and GSTP1 were analyzed by methylation specific polymerase chain reaction (MSP) in 70 specimens of breast carcinomas and 79 pairs of tumor and matched adjacent normal tissues from breast cancer patients. Results: All the three analyzed genes showed a concordance concerning their promoter methylation in tumor and adjacent normal tissue. The methylation of BRCA1, RASSF1A and GSTP1 was found in 58.23 %, 74.68 % and 59.49 % of tumor tissues and 51.90 %, 63.29 % and 35.44 % of corresponding adjacent tissues, respectively. When each gene was assessed individually, only the methylation of GSTP1 was significantly associated with tumor tissues (p=0.003). However, the methylation frequency of at least one of the three genes and the methylation frequency of all the three genes both showed significant association with tumor (p=0.008 and p=0.04, respectively). The methylation of BRCA1 was found to be significantly associated with tumor grade (p=0.01). Conclusion: This study emphasized that the panel of the three genes BRCA1, RASSF1A and GSTP1 can be further developed as potential biomarkers in diagnosis and classification of breast cancer in Vietnamese women.

摘要

目的

本研究分别及综合调查BRCA1、RASSF1A和GSTP1基因的DNA启动子甲基化谱,以阐明它们与越南乳腺癌患者临床病理参数的相关性,并建立用于乳腺癌检测的新的潜在综合甲基化生物标志物。材料与方法:采用甲基化特异性聚合酶链反应(MSP)分析70例乳腺癌标本及79对乳腺癌患者肿瘤组织与配对癌旁正常组织中BRCA1、RASSF1A和GSTP1的甲基化频率。结果:所分析的三个基因在肿瘤组织和癌旁正常组织中的启动子甲基化情况具有一致性。BRCA1、RASSF1A和GSTP1在肿瘤组织中的甲基化率分别为58.23%、74.68%和59.49%,在相应癌旁组织中的甲基化率分别为51.90%、63.29%和35.44%。单独评估每个基因时,只有GSTP1的甲基化与肿瘤组织显著相关(p = 0.003)。然而,三个基因中至少一个基因的甲基化频率以及三个基因全部的甲基化频率均与肿瘤显著相关(分别为p = 0.008和p = 0.04)。发现BRCA1的甲基化与肿瘤分级显著相关(p = 0.01)。结论:本研究强调,BRCA1、RASSF1A和GSTP1这三个基因组合可进一步开发为越南女性乳腺癌诊断和分类的潜在生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e34e/6165660/fb6cf9b16853/APJCP-19-1887-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e34e/6165660/6efd8622c4a7/APJCP-19-1887-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e34e/6165660/fb6cf9b16853/APJCP-19-1887-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e34e/6165660/6efd8622c4a7/APJCP-19-1887-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e34e/6165660/fb6cf9b16853/APJCP-19-1887-g002.jpg

相似文献

1
Methylation Profiles of BRCA1, RASSF1A and GSTP1 in Vietnamese Women with Breast Cancer.越南乳腺癌女性中BRCA1、RASSF1A和GSTP1的甲基化谱
Asian Pac J Cancer Prev. 2018 Jul 27;19(7):1887-1893. doi: 10.22034/APJCP.2018.19.7.1887.
2
Promoter Methylation of BRCA1, DAPK1 and RASSF1A is Associated with Increased Mortality among Indian Women with Breast Cancer.BRCA1、DAPK1和RASSF1A的启动子甲基化与印度乳腺癌女性死亡率增加有关。
Asian Pac J Cancer Prev. 2018 Feb 26;19(2):443-448. doi: 10.22034/APJCP.2018.19.2.443.
3
Applicability of HIN-1, MGMT and RASSF1A promoter methylation as biomarkers for detecting field cancerization in breast cancer.HIN-1、MGMT和RASSF1A启动子甲基化作为检测乳腺癌场癌化生物标志物的适用性。
Breast Cancer Res. 2015 Sep 14;17(1):125. doi: 10.1186/s13058-015-0637-5.
4
Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients.肿瘤中 DNA 修复基因启动子超甲基化和浸润性导管乳腺癌患者血清 DNA 的临床意义。
Life Sci. 2010 Jul 17;87(3-4):83-91. doi: 10.1016/j.lfs.2010.05.001. Epub 2010 May 12.
5
Methylation profile of BRCA1, RASSF1A and ER in Vietnamese women with ovarian cancer.越南卵巢癌女性中BRCA1、RASSF1A和雌激素受体的甲基化谱
Asian Pac J Cancer Prev. 2013;14(12):7713-8. doi: 10.7314/apjcp.2013.14.12.7713.
6
Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.抑癌基因 RASSF1A、GSTP1 和 CDH1 在子宫内膜癌中的启动子异常甲基化。
Oncol Rep. 2013 Dec;30(6):2878-86. doi: 10.3892/or.2013.2752. Epub 2013 Sep 25.
7
Prognostic relevance of promoter hypermethylation of multiple genes in breast cancer patients.乳腺癌患者中多个基因启动子高甲基化的预后相关性
Cell Oncol. 2009;31(6):487-500. doi: 10.3233/CLO-2009-0507.
8
ABERRANT METHYLATION OF CANCER-RELATED GENES IN VIETNAMESE BREAST CANCER PATIENTS: ASSOCIATIONS WITH CLINICOPATHOLOGICAL FEATURES.越南乳腺癌患者中与癌症相关基因的异常甲基化:与临床病理特征的关联。
Exp Oncol. 2023 Oct 11;45(2):195-202. doi: 10.15407/exp-oncology.2023.02.195.
9
Soy phytoestrogens modify DNA methylation of GSTP1, RASSF1A, EPH2 and BRCA1 promoter in prostate cancer cells.大豆植物雌激素修饰前列腺癌细胞中 GSTP1、RASSF1A、EPH2 和 BRCA1 启动子的 DNA 甲基化。
In Vivo. 2010 Jul-Aug;24(4):393-400.
10
Promoter methylation profile of GSTP1 and RASSF1A in prostate cancerand benign hyperplasia in Vietnamese men.在越南男性的前列腺癌和良性增生中 GSTP1 和 RASSF1A 的启动子甲基化谱。
Turk J Med Sci. 2016 Jan 5;46(1):228-35. doi: 10.3906/sag-1410-65.

引用本文的文献

1
A Review on the Impact of Aberrant Methylation in Breast Cancer: Diagnostic, Prognostic, and Therapeutic Approaches.乳腺癌中异常甲基化的影响综述:诊断、预后及治疗方法
Iran J Biotechnol. 2024 Oct 1;22(4):e3897. doi: 10.30498/ijb.2024.447513.3897. eCollection 2024 Oct.
2
BRCA1 & BRCA2 methylation as a prognostic and predictive biomarker in cancer: Implementation in liquid biopsy in the era of precision medicine.BRCA1和BRCA2甲基化作为癌症的预后和预测生物标志物:在精准医学时代液体活检中的应用
Clin Epigenetics. 2024 Dec 6;16(1):178. doi: 10.1186/s13148-024-01787-8.
3
BRCA1 Promoter Hypermethylation in Malignant Breast Tumors and in the Histologically Normal Adjacent Tissues to the Tumors: Exploring Its Potential as a Biomarker and Its Clinical Significance in a Translational Approach.

本文引用的文献

1
Genomic Markers in Prostate Cancer Decision Making.前列腺癌决策中的基因组标志物。
Eur Urol. 2018 Apr;73(4):572-582. doi: 10.1016/j.eururo.2017.10.036. Epub 2017 Nov 10.
2
DNA Methylation as a Noninvasive Epigenetic Biomarker for the Detection of Cancer.DNA 甲基化作为一种非侵入性的表观遗传生物标志物用于癌症的检测。
Dis Markers. 2017;2017:3726595. doi: 10.1155/2017/3726595. Epub 2017 Sep 5.
3
Epigenetic regulation of gene expression in cancer: techniques, resources and analysis.癌症中基因表达的表观遗传调控:技术、资源与分析。
恶性乳腺肿瘤及其组织学正常的肿瘤旁组织中BRCA1启动子高甲基化:从转化医学角度探讨其作为生物标志物的潜力及其临床意义
Genes (Basel). 2023 Aug 25;14(9):1680. doi: 10.3390/genes14091680.
4
Methylation of promoter region of BRCA1 gene versus pathogenic variants of gene: risk factor or clinical marker of breast cancer.BRCA1 基因启动子区域甲基化与基因致病性变异:乳腺癌的风险因素还是临床标志物。
Breast Cancer Res Treat. 2022 Dec;196(3):505-515. doi: 10.1007/s10549-022-06774-2. Epub 2022 Oct 25.
5
Epigenetic alterations in canine mammary cancer.犬类乳腺癌中的表观遗传改变。
Genet Mol Biol. 2022 Oct 24;45(3 Suppl 1):e20220131. doi: 10.1590/1678-4685-GMB-2022-0131. eCollection 2022.
6
Suppression of Tumorigenicity 5 Ameliorates Tumor Characteristics of Invasive Breast Cancer Cells ERK/JNK Pathway.抑癌基因5改善侵袭性乳腺癌细胞的肿瘤特性 ERK/JNK信号通路。
Front Oncol. 2021 Jul 28;11:621500. doi: 10.3389/fonc.2021.621500. eCollection 2021.
7
The Clinical and Pathological Profile of BRCA1 Gene Methylated Breast Cancer Women: A Meta-Analysis.BRCA1基因甲基化乳腺癌女性的临床和病理特征:一项荟萃分析。
Cancers (Basel). 2021 Mar 19;13(6):1391. doi: 10.3390/cancers13061391.
8
Circulating Cell-Free Nucleic Acids as Epigenetic Biomarkers in Precision Medicine.循环游离核酸作为精准医学中的表观遗传生物标志物
Front Genet. 2020 Aug 11;11:844. doi: 10.3389/fgene.2020.00844. eCollection 2020.
9
The association between the methylation frequency of BRCA1/2 gene promoter and occurrence and prognosis of breast carcinoma: A meta-analysis.BRCA1/2基因启动子甲基化频率与乳腺癌发生及预后的相关性:一项Meta分析。
Medicine (Baltimore). 2020 Mar;99(10):e19345. doi: 10.1097/MD.0000000000019345.
10
Peripheral Blood-Based Biopsy for Breast Cancer Risk Prediction and Early Detection.基于外周血的活检用于乳腺癌风险预测和早期检测。
Front Med (Lausanne). 2020 Feb 11;7:28. doi: 10.3389/fmed.2020.00028. eCollection 2020.
Brief Funct Genomics. 2018 Jan 1;17(1):49-63. doi: 10.1093/bfgp/elx018.
4
Improved prediction of breast cancer outcome by identifying heterogeneous biomarkers.通过鉴定异质生物标志物改善乳腺癌预后预测。
Bioinformatics. 2017 Nov 15;33(22):3619-3626. doi: 10.1093/bioinformatics/btx487.
5
Prognostic role of methylated GSTP1, p16, ESR1 and PITX2 in patients with breast cancer: A systematic meta-analysis under the guideline of PRISMA.甲基化 GSTP1、p16、ESR1 和 PITX2 在乳腺癌患者中的预后作用:一项遵循 PRISMA 指南的系统荟萃分析
Medicine (Baltimore). 2017 Jul;96(28):e7476. doi: 10.1097/MD.0000000000007476.
6
DNA methylation markers for diagnosis and prognosis of common cancers.用于常见癌症诊断和预后的 DNA 甲基化标志物。
Proc Natl Acad Sci U S A. 2017 Jul 11;114(28):7414-7419. doi: 10.1073/pnas.1703577114. Epub 2017 Jun 26.
7
Promoter methylation and gene polymorphism are two independent events in regulation of GSTP1 gene expression.启动子甲基化和基因多态性是GSTP1基因表达调控中的两个独立事件。
Tumour Biol. 2017 Apr;39(4):1010428317697563. doi: 10.1177/1010428317697563.
8
Detection of Methylated Circulating DNA as Noninvasive Biomarkers for Breast Cancer Diagnosis.检测甲基化循环DNA作为乳腺癌诊断的非侵入性生物标志物
J Breast Cancer. 2017 Mar;20(1):12-19. doi: 10.4048/jbc.2017.20.1.12. Epub 2017 Mar 24.
9
Diagnostic Accuracy of Methylated SEPT9 for Blood-based Colorectal Cancer Detection: A Systematic Review and Meta-Analysis.用于基于血液的结直肠癌检测的甲基化SEPT9的诊断准确性:一项系统评价和荟萃分析。
Clin Transl Gastroenterol. 2017 Jan 19;8(1):e216. doi: 10.1038/ctg.2016.66.
10
Blood-based DNA methylation as biomarker for breast cancer: a systematic review.基于血液的DNA甲基化作为乳腺癌生物标志物的系统评价
Clin Epigenetics. 2016 Nov 14;8:115. doi: 10.1186/s13148-016-0282-6. eCollection 2016.